Endothelial function in migraine: A cross-sectional study

BMC Neurology

Volumn 10, Issue , 2010, Pages

  Vanmolkot, Floris H ^a   De Hoon, Jan N ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

N(G) METHYLARGININE; NITROPRUSSIDE SODIUM; SUBSTANCE P; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; ENDOTHELIAL DYSFUNCTION; FEMALE; FOREARM BLOOD FLOW; HUMAN; MALE; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; TREATMENT RESPONSE; VEIN OCCLUSION PLETHYSMOGRAPHY; BLOOD FLOW; DRUG EFFECT; FOREARM; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM; VASCULARIZATION; VASODILATATION;

ADULT; ANALYSIS OF VARIANCE; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FEMALE; FOREARM; HUMANS; MALE; MIGRAINE DISORDERS; NITROPRUSSIDE; OMEGA-N-METHYLARGININE; REGIONAL BLOOD FLOW; SUBSTANCE P; TISSUE PLASMINOGEN ACTIVATOR; VASODILATION;

EID: 78649512773     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-10-119     Document Type: Article

References (39)

1. Silberstein SD. Migraine. Lancet 2004, 363:381-391. 10.1016/S0140-6736(04)15440-8, 15070571.
2. Pietrobon D, Striessnig J. Neurobiology of migraine. Nat Rev Neurosci 2003, 4:386-398. 10.1038/nrn1102, 12728266.
3. Bousser MG, Welch KM. Relation between migraine and stroke. Lancet Neurol 2005, 4:533-542. 10.1016/S1474-4422(05)70164-2, 16109360.
4. Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE. Migraine and risk of cardiovascular disease in women. JAMA 2006, 296:283-291. 10.1001/jama.296.3.283, 16849661.
5. Miller D, Waters DD, Warnica W, Szlachcic J, Kreeft J, Theroux P. Is variant angina the coronary manifestation of a generalized vasospastic disorder?. N Engl J Med 1981, 304:763-766. 10.1056/NEJM198103263041306, 7464885.
6. O'Keeffe ST, Tsapatsaris NP, Beetham WP. Increased prevalence of migraine and chest pain in patients with primary Raynaud disease. Ann Intern Med 1992, 116:985-989.
7. Stam AH, Haan J, van den Maagdenberg AM, Ferrari MD, Terwindt GM. Migraine and genetic and acquired vasculopathies. Cephalalgia 2009, 29:1006-1017. 10.1111/j.1468-2982.2009.01940.x, 19689610.
8. Appenzeller O. Pathogenesis of migraine. Med Clin North Am 1991, 75:763-789.
9. Landmesser U, Hornig B, Drexler H. Endothelial function: a critical determinant in atherosclerosis?. Circulation 2004, 109:II27-33. 10.1161/01.CIR.0000129501.88485.1f, 15173060.
10. Gabrielli M, Santarelli L, Addolorato G, Foschi G, Di Gampli C, Gasbarrini A, Fiore G, Cristiana DC. High prevalence of antiendothelial cell antibodies in migraine. Headache 2002, 42:385-386. 10.1046/j.1526-4610.2002.02114.x, 12047343.
11. Gallai V, Sarchielli P, Firenze C, Trequattrini A, Paciaroni M, Usai F, Palumbo R. Endothelin 1 in migraine and tension-type headache. Acta Neurol Scand 1994, 89:47-55. 10.1111/j.1600-0404.1994.tb01632.x, 8178628.
12. Tietjen GE, Al-Qasmi MM, Athanas K, Dafer RM, Khuder SA. Increased von Willebrand factor in migraine. Neurology 2001, 57:334-336.
13. Dreier JP, Kleeberg J, Petzold G, Priller J, Windmuller O, Orzechowski HD, Lindauer U, Heinemann U, Einhaupl KM, Dirnagl U. Endothelin-1 potently induces Leao's cortical spreading depression in vivo in the rat: a model for an endothelial trigger of migrainous aura?. Brain 2002, 125:102-112. 10.1093/brain/awf007, 11834596.
14. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004, 24(Suppl 1):9-160.
15. Tom T, Brody M, Valabhji A, Turner L, Molgaard C, Rothrock J. Validation of a new instrument for determining migraine prevalence: the UCSD Migraine Questionnaire. Neurology 1994, 44:925-928.
16. Newby DE, Wright RA, Ludlam CA, Fox KA, Boon NA, Webb DJ. An in vivo model for the assessment of acute fibrinolytic capacity of the endothelium. Thromb Haemost 1997, 78:1242-1248.
17. Kneale BJ, Chowienczyk PJ, Brett SE, Cockcroft JR, Ritter JM. Forearm vasoconstriction in response to noradrenaline and NG-monomethyl-L-arginine in essential hypertension. Clin Sci (Lond) 1999, 97:277-282. 10.1042/CS19990072, 10464052.
18. Wilkinson IB, Webb DJ. Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications. Br J Clin Pharmacol 2001, 52:631-646. 10.1046/j.0306-5251.2001.01495.x, 2014568, 11736874.
19. Holvoet P, Cleemput H, Collen D. Assay of human tissue-type plasminogen activator (t-PA) with an enzyme-linked immunosorbent assay (ELISA) based on three murine monoclonal antibodies to t-PA. Thromb Haemost 1985, 54:684-687.
20. Vanmolkot FH, de Hoon JN. Reproducibility of forearm vasodilator response to intra-arterial infusion of calcitonin gene-related peptide assessed by venous occlusion plethysmography. Br J Clin Pharmacol 2005, 59:387-397. 10.1111/j.1365-2125.2005.02333.x, 1884797, 15801933.
21. Oliver JJ, Webb DJ, Newby DE. Stimulated tissue plasminogen activator release as a marker of endothelial function in humans. Arterioscler Thromb Vasc Biol 2005, 25:2470-2479. 10.1161/01.ATV.0000189309.05924.88, 16210566.
22. Newby DE, Sciberras DG, Mendel CM, Gertz BJ, Boon NA, Webb DJ. Intra-arterial substance P mediated vasodilatation in the human forearm: pharmacology, reproducibility and tolerability. Br J Clin Pharmacol 1997, 43:493-499. 10.1046/j.1365-2125.1997.00583.x, 2042777, 9159564.
23. D'Amico D, Ferraris A, Leone M, Catania A, Carlin A, Grazzi L, Bussone G. Increased plasma nitrites in migraine and cluster headache patients in interictal period: basal hyperactivity of L-arginine-NO pathway?. Cephalalgia 2002, 22:33-36. 10.1046/j.1468-2982.2002.00304.x, 11993611.
24. Gallai V, Floridi A, Mazzotta G, Codini M, Tognoloni M, Vulcano MR, Sartori M, Russo S, Alberti A, Michele F, Sarchielli P. L-arginine/nitric oxide pathway activation in platelets of migraine patients with and without aura. Acta Neurol Scand 1996, 94:151-160. 10.1111/j.1600-0404.1996.tb07046.x, 8891062.
25. Sarchielli P, Tognoloni M, Russo S, Vulcano MR, Feleppa M, Mala M, Sartori M, Gallai V. Variations in the platelet arginine/nitric oxide pathway during the ovarian cycle in females affected by menstrual migraine. Cephalalgia 1996, 16:468-475. 10.1046/j.1468-2982.1996.1607468.x, 8933990.
26. Napoli R, Guardasole V, Zarra E, Matarazzo M, D'Anna C, Sacca F, Affuso F, Cittadini A, Carrieri PB, Sacca L. Vascular smooth muscle cell dysfunction in patients with migraine. Neurology 2009, 72:2111-2114. 10.1212/WNL.0b013e3181aa53ce, 19528518.
27. de Hoon JN, Smits P, Troost J, Struijker-Boudier HA, Van Bortel LM. Forearm vascular response to nitric oxide and calcitonin gene-related peptide: comparison between migraine patients and control subjects. Cephalalgia 2006, 26:56-63. 10.1111/j.1468-2982.2005.00993.x, 16396667.
28. Edvinsson ML, Edvinsson L. Comparison of CGRP and NO responses in the human peripheral microcirculation of migraine and control subjects. Cephalalgia 2008, 28:563-566. 10.1111/j.1468-2982.2008.01558.x, 18384419.
29. Yetkin E, Ozisik H, Ozcan C, Aksoy Y, Turhan H. Increased dilator response to nitrate and decreased flow-mediated dilatation in migraineurs. Headache 2007, 47:104-110.
30. Thomsen LL, Iversen HK, Brinck TA, Olesen J. Arterial supersensitivity to nitric oxide (nitroglycerin) in migraine sufferers. Cephalalgia 1993, 13:395-399. 10.1046/j.1468-2982.1993.1306395.x, 7906202.
31. Thomsen LL, Daugaard D, Iversen H, Olesen J. Normal radial artery dilatation during reactive hyperaemia in migraine without aura. Endothelium 1996, 4:199-206.
32. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002, 39:257-265. 10.1016/S0735-1097(01)01746-6, 11788217.
33. Yetkin E, Ozisik H, Ozcan C, Aksoy Y, Turhan H. Decreased endothelium-dependent vasodilatation in patients with migraine: a new aspect to vascular pathophysiology of migraine. Coron Artery Dis 2006, 17:29-33. 10.1097/00019501-200602000-00005, 16374138.
34. Vanmolkot FH, Van Bortel LM, de Hoon JN. Altered arterial function in migraine of recent onset. Neurology 2007, 68:1563-1570. 10.1212/01.wnl.0000260964.28393.ed, 17460157.
35. Silva FA, Rueda-Clausen CF, Silva SY, Zarruk JG, Guzman JC, Morillo CA, Vesga B, Pradilla G, Florez M, Lopez-Jaramillo P. Endothelial function in patients with migraine during the interictal period. Headache 2007, 47:45-51. 10.1111/j.1526-4610.2006.00532.x, 17355493.
36. Crassard I, Conard J, Bousser MG. Migraine and haemostasis. Cephalalgia 2001, 21:630-636. 10.1046/j.1468-2982.2001.00205.x, 11531894.
37. Tietjen GE, Herial NA, White L, Utley C, Kosmyna JM, Khuder SA. Migraine and biomarkers of endothelial activation in young women. Stroke 2009, 40:2977-2982. 10.1161/STROKEAHA.109.547901, 19608996.
38. Stang PE, Carson AP, Rose KM, Mo J, Ephross SA, Shahar E, Szklo M. Headache, cerebrovascular symptoms, and stroke: the Atherosclerosis Risk in Communities Study. Neurology 2005, 64:1573-1577. 10.1212/01.WNL.0000158326.31368.04, 15883318.
39. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, Lieberman EH, Ganz P, Creager MA, Yeung AC, et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995, 26:1235-1241. 10.1016/0735-1097(95)00327-4, 7594037.